​

Elevai Labs Stock (NASDAQ:ELAB)

RevenueFinancialsChart
Elevai Labs by TradingView

Previous Close

$2.56

52W Range

$1.74 - $778.00

50D Avg

$7.79

200D Avg

$77.01

Market Cap

$8.02M

Avg Vol (3M)

$1.25M

Beta

-

Div Yield

-

ELAB Company Profile

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

18

IPO Date

-

Website

-

ELAB Performance

ELAB Financial Summary

Dec 23Dec 22Dec 21
Revenue$1.71M$766.28K$827.00
Operating Income$-3.76M$-1.79M$-785.06K
Net Income$-4.30M$-1.80M$-784.74K
EBITDA$-3.75M$-1.78M$-782.30K
Basic EPS$-0.40$-0.19$-0.08
Diluted EPS$-0.40$-0.19$-0.08

Fiscal year ends in Dec 23 | Currency in USD